226 related articles for article (PubMed ID: 25768865)
1. Assessment of the impact of cotrimoxazole prophylaxis on key outcomes among HIV-infected adults in low- and middle-income countries: a systematic review.
Saadani Hassani A; Marston BJ; Kaplan JE
J Acquir Immune Defic Syndr; 2015 Apr; 68 Suppl 3(Suppl 3):S257-69. PubMed ID: 25768865
[TBL] [Abstract][Full Text] [Related]
2. Impact of cotrimoxazole and insecticide-treated nets for malaria prevention on key outcomes among HIV-infected adults in low- and middle-income countries: a systematic review.
Saadani Hassani A; Marston BJ
J Acquir Immune Defic Syndr; 2015 Apr; 68 Suppl 3(Suppl 3):S306-17. PubMed ID: 25768870
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of cotrimoxazole prophylaxis among persons with HIV in Uganda.
Pitter C; Kahn JG; Marseille E; Lule JR; McFarland DA; Ekwaru JP; Bunnell R; Coutinho A; Mermin J
J Acquir Immune Defic Syndr; 2007 Mar; 44(3):336-43. PubMed ID: 17327758
[TBL] [Abstract][Full Text] [Related]
4. Cotrimoxazole for prophylaxis or treatment of opportunistic infections of HIV/AIDS in patients with previous history of hypersensitivity to cotrimoxazole.
Lin D; Li WK; Rieder MJ
Cochrane Database Syst Rev; 2007 Apr; (2):CD005646. PubMed ID: 17443608
[TBL] [Abstract][Full Text] [Related]
5. Cotrimoxazole prophylaxis for opportunistic infections in adults with HIV.
Grimwade K; Swingler ; G
Cochrane Database Syst Rev; 2003; 2003(3):CD003108. PubMed ID: 12917946
[TBL] [Abstract][Full Text] [Related]
6. The impact of HIV care and support interventions on key outcomes in low- and middle-income countries: a literature review--introduction.
Kaplan JE; Hamm TE; Forhan S; Saadani Hassani A; Bang G; Weyant E; Tchuenche M; Langley C; Lapidos-Salaiz I; Bateganya MH
J Acquir Immune Defic Syndr; 2015 Apr; 68 Suppl 3(Suppl 3):S253-6. PubMed ID: 25768864
[No Abstract] [Full Text] [Related]
7. Cotrimoxazole prophylaxis for opportunistic infections in children with HIV infection.
Grimwade K; Swingler GH
Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD003508. PubMed ID: 16437457
[TBL] [Abstract][Full Text] [Related]
8. The impact of social services interventions in developing countries: a review of the evidence of impact on clinical outcomes in people living with HIV.
Bateganya MH; Dong M; Oguntomilade J; Suraratdecha C
J Acquir Immune Defic Syndr; 2015 Apr; 68 Suppl 3(0 3):S357-67. PubMed ID: 25768875
[TBL] [Abstract][Full Text] [Related]
9. Nutrition assessment, counseling, and support interventions to improve health-related outcomes in people living with HIV/AIDS: a systematic review of the literature.
Tang AM; Quick T; Chung M; Wanke CA
J Acquir Immune Defic Syndr; 2015 Apr; 68 Suppl 3(0 3):S340-9. PubMed ID: 25768873
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire.
Goldie SJ; Yazdanpanah Y; Losina E; Weinstein MC; Anglaret X; Walensky RP; Hsu HE; Kimmel A; Holmes C; Kaplan JE; Freedberg KA
N Engl J Med; 2006 Sep; 355(11):1141-53. PubMed ID: 16971720
[TBL] [Abstract][Full Text] [Related]
11. Safety of discontinuing cotrimoxazole prophylaxis among HIV infected adults on anti-retroviral therapy in Uganda (COSTOP trial): Design.
Anywaine Z; Abaasa A; Levin J; Kasirye R; Kamali A; Grosskurth H; Munderi P; Nunn A
Contemp Clin Trials; 2015 Jul; 43():100-4. PubMed ID: 26009024
[TBL] [Abstract][Full Text] [Related]
12. Improving rates of cotrimoxazole prophylaxis in resource-limited settings: implementation of a quality improvement approach.
Bardfield J; Agins B; Palumbo M; Wei AL; Morris J; Marston B;
Int J Qual Health Care; 2014 Dec; 26(6):613-22. PubMed ID: 25335758
[TBL] [Abstract][Full Text] [Related]
13. Cryptococcal antigen screening and early antifungal treatment to prevent cryptococcal meningitis: a review of the literature.
Kaplan JE; Vallabhaneni S; Smith RM; Chideya-Chihota S; Chehab J; Park B
J Acquir Immune Defic Syndr; 2015 Apr; 68 Suppl 3():S331-9. PubMed ID: 25768872
[TBL] [Abstract][Full Text] [Related]
14. Cotrimoxazole prophylaxis for opportunistic infections in children with HIV infection.
Grimwade K; Swingler G
Cochrane Database Syst Rev; 2003; (2):CD003508. PubMed ID: 12804472
[TBL] [Abstract][Full Text] [Related]
15. The cost-effectiveness of cotrimoxazole in people with advanced HIV infection initiating antiretroviral therapy in sub-Saharan Africa.
Abimbola TO; Marston BJ
J Acquir Immune Defic Syndr; 2012 May; 60(1):e8-e14. PubMed ID: 22240461
[TBL] [Abstract][Full Text] [Related]
16. Co-trimoxazole prophylaxis in adults, including pregnant women, with HIV: a systematic review and meta-analysis.
Suthar AB; Vitoria MA; Nagata JM; Anglaret X; Mbori-Ngacha D; Sued O; Kaplan JE; Doherty MC
Lancet HIV; 2015 Apr; 2(4):e137-50. PubMed ID: 26424674
[TBL] [Abstract][Full Text] [Related]
17. The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in Zambia.
Ryan M; Griffin S; Chitah B; Walker AS; Mulenga V; Kalolo D; Hawkins N; Merry C; Barry MG; Chintu C; Sculpher MJ; Gibb DM
AIDS; 2008 Mar; 22(6):749-57. PubMed ID: 18356605
[TBL] [Abstract][Full Text] [Related]
18. Feasibility and effectiveness of cotrimoxazole prophylaxis for HIV-1-infected adults attending an HIV/AIDS clinic in Uganda.
Watera C; Todd J; Muwonge R; Whitworth J; Nakiyingi-Miiro J; Brink A; Miiro G; Antvelink L; Kamali A; French N; Mermin J
J Acquir Immune Defic Syndr; 2006 Jul; 42(3):373-8. PubMed ID: 16810124
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysis.
Yazdanpanah Y; Losina E; Anglaret X; Goldie SJ; Walensky RP; Weinstein MC; Toure S; Smith HE; Kaplan JE; Freedberg KA;
AIDS; 2005 Aug; 19(12):1299-308. PubMed ID: 16052085
[TBL] [Abstract][Full Text] [Related]
20. Reduction in preterm delivery and neonatal mortality after the introduction of antenatal cotrimoxazole prophylaxis among HIV-infected women with low CD4 cell counts.
Walter J; Mwiya M; Scott N; Kasonde P; Sinkala M; Kankasa C; Kauchali S; Aldrovandi GM; Thea DM; Kuhn L
J Infect Dis; 2006 Dec; 194(11):1510-8. PubMed ID: 17083035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
